SFPI-FPIM

Total investments

39

Average round size

25M

Portfolio companies

26

Rounds per year

2.17

Lead investments

2

Follow on index

0.33

Exits

2

Areas of investment
BiotechnologyInformation TechnologyHealth CareHealth DiagnosticsAerospaceManufacturingMedical DeviceMedicalPharmaceuticalTherapeutics

Summary

SFPI-FPIM is the famous VC, which was founded in 2006. The main office of represented VC is situated in the Brussels. The company was established in Europe in Belgium.

The fund is generally included in 2-6 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. Considering the real fund results, this VC is 10 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2018. Opposing the other organizations, this SFPI-FPIM works on 24 percentage points less the average amount of lead investments.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the SFPI-FPIM, startups are often financed by Capricorn Venture Partners, S.R.I.W., BioMedPartners. The meaningful sponsors for the fund in investment in the same round are Capricorn Venture Partners, PMV, Meusinvest. In the next rounds fund is usually obtained by S.R.I.W., Vesalius Biocapital Partners, Gimv.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. The fund has exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight iSTAR Medical, Miracor Medical, ITeos Therapeutics. Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics.

Show more

Investments analytics

Analytics

Total investments
39
Lead investments
2
Exits
2
Rounds per year
2.17
Follow on index
0.33
Investments by industry
  • Health Care (20)
  • Biotechnology (16)
  • Medical (11)
  • Medical Device (9)
  • Manufacturing (8)
  • Show 40 more
Investments by region
  • Belgium (29)
  • United States (4)
  • The Netherlands (1)
  • France (2)
  • Netherlands (2)
  • Show 1 more
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
1M
Group Appearance index
0.97

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Barosi 01 Jan 2016 Food and Beverage, Food Processing, Grocery, Nutrition, Organic Food, Fast-Moving Consumer Goods, Food Delivery, Farmers Market Seed Haryana, Gurgaon, India
Ncardia 17 Nov 2017 Biotechnology, Health Care, Medical, Pharmaceutical Early Stage Venture 12M South Holland, Leiden, Netherlands
Qpinch 09 Sep 2021 Energy, Renewable Energy, Energy Efficiency, Clean Energy Early Stage Venture 16M Antwerpen, Antwerp, Belgium
TELEPORT 23 Jan 2019 Transportation, Information Technology, B2B, Travel, B2C, Taxi Service Seed 185K Russian Federation, Sakhalin Oblast, Russia
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.